Evolution of hepatic fibrosis and steatosis during long-term use of metformin in patients with type 2 diabetes

被引：0
作者：
Lee, Hye Won [1 ]
Kim, Seung Up [1 ]
Lee, Jae Seung [1 ]
Kim, Beom Kyung [1 ]
Park, Jun Yong [1 ]
Kim, Do Young [1 ]
Ahn, Sang Hoon [1 ]
Han, Kwang-Hyub [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU032
引用
收藏
页码：S156 / S157
页数：2
相关论文
共 50 条
[31]   Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery [J].
Lautenbach, Anne ;
Wernecke, Marie ;
Mann, Oliver ;
Wagner, Jonas ;
Wolter, Stefan ;
Stoll, Fabian ;
Aberle, Jens .
OBESITY SURGERY, 2023, 33 (02) :530-538
[32]   Low-Grade Hepatic Steatosis Is Associated with Long-term Remission of Type 2 Diabetes Independent of Type of Bariatric-Metabolic Surgery [J].
Anne Lautenbach ;
Marie Wernecke ;
Oliver Mann ;
Jonas Wagner ;
Stefan Wolter ;
Fabian Stoll ;
Jens Aberle .
Obesity Surgery, 2023, 33 :530-538
[33]   Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitus [J].
Odawara M. ;
Kawamori R. ;
Tajima N. ;
Iwamoto Y. ;
Kageyama S. ;
Yodo Y. ;
Ueki F. ;
Hotta N. .
Diabetology International, 2017, 8 (3) :286-295
[34]   HEPATIC-FIBROSIS DURING LONG-TERM METHOTREXATE THERAPY [J].
RICCIBLUE, P ;
GROSS, JB ;
MCGILL, DB .
HEPATOLOGY, 1994, 20 (04) :A189-A189
[35]   Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study [J].
Matthews, DR ;
Charbonnel, BH ;
Hanefeld, M ;
Brunetti, P ;
Schernthaner, G .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (02) :167-174
[36]   Simulating long-term outcomes of liraglutide plus metformin versus metformin and metformin plus glimepiride in type 2 diabetes patients with inadequate glycaemic control [J].
Valentine, WJ ;
Wittrup-Jensen, KU ;
Nicklasson, L ;
Roze, S ;
Palmer, AJ ;
Nauck, MA .
DIABETES, 2005, 54 :A613-A613
[37]   The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease [J].
Kwon, Soie ;
Kim, Yong Chul ;
Park, Jae Yoon ;
Lee, Jeonghwan ;
An, Jung Nam ;
Kim, Clara Tammy ;
Oh, Sohee ;
Park, Seokwoo ;
Kim, Dong Ki ;
Oh, Yun Kyu ;
Kim, Yon Su ;
Lim, Chun Soo ;
Lee, Jung Pyo .
DIABETES CARE, 2020, 43 (05) :948-955
[38]   HEPATIC STEATOSIS AS DIABETES TYPE 2 PREDICTOR [J].
Loureiro, Carolina ;
Martinez-Aguayo, Alejandro ;
Campino, Carmen ;
Carvajal, Cristian ;
Fardella, Carlos ;
Garcia, Hernan .
NUTRICION HOSPITALARIA, 2014, 29 (02) :350-358
[39]   Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes [J].
Roden, M. ;
Mariz, S. ;
Brazzale, A. R. ;
Pacini, G. .
JOURNAL OF INTERNAL MEDICINE, 2009, 265 (04) :476-487
[40]   Hepatic Steatosis and Fibrosis Are Significantly Associated with Left Ventricular Diastolic Dysfunction in Elderly Patients with Type 2 Diabetes [J].
Shin, Sungjae ;
Kim, Gyuri ;
Lee, Hokyou ;
Kim, So Ra ;
Lee, Byung Wan ;
Kang, Eun Seok ;
Ahn, Chul Woo ;
Cha, Bong Soo ;
Huh, Kap Bum ;
Lee, Yong Ho .
DIABETES, 2017, 66 :A410-A411
12345